A preclinical characterization of CJC-1295 focus on GHRHR ligand binding kinetics, Gs-coupled adenylate cyclase transducti…

An in-depth, systems-level preclinical research synthesis of CJC-1295’s interaction with GHRHR and pituitary adenylate cyclase dynamics.

A detailed study on GHRH receptor Gs-protein coupling kinetics and adenylate cyclase dynamics under somatostatin challenge by CJC-1295.

Receptor Coupling Kinetics: CJC-1295 Interaction with GHRHR and Pituitary Adenylate Cyclase Dynamics

← Back to The GH Pulse Receptor Coupling Kinetics: CJC-1295 Interaction with GHRHR and Pituitary Adenylate Cyclase Dynamics Section 1: Compound Overview (Research Context Only) CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) distinguished by a covalently attached Drug Affinity Complex (DAC) moiety—specifically a maleimido-propionic acid linker. In preclinical models, this modification enables […]

Investigating CJC-1295 GHRHR receptor dynamics and somatotroph secretion kinetics under physiological feedback.

An exploration of CJC-1295 binding kinetics, pituitary GHRHR Gs/cAMP/PKA signaling, and tonic somatotroph stimulation without somatostatin suppression.

A research-context examination of CJC-1295 with DAC pharmacokinetics, including the albumin-binding half-life extension mechanism, prolonged pituitary somatotroph stimulation kinetics, and cumulative IGF-1 axis characterization in pharmacological studies.